{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T01:11:54Z","timestamp":1784941914633,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Med"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s40290-023-00482-y","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T07:01:41Z","timestamp":1686207701000},"page":"377-384","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Perspectives on Adherence to Glaucoma Medical Therapy in Brazilian Patients"],"prefix":"10.1007","volume":"37","author":[{"given":"Julia","family":"da Costa Andrade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Samomiya","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4101-0304","authenticated-orcid":false,"given":"Niro","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"482_CR1","doi-asserted-by":"crossref","unstructured":"Heijl A, Leske MC, Bengtsson B, et al. Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression. Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268\u201379.","DOI":"10.1001\/archopht.120.10.1268"},{"key":"482_CR2","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"MA Kass","year":"2002","unstructured":"Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701\u201313 (discussion 829\u201330).","journal-title":"Arch Ophthalmol."},{"key":"482_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/IJG.0b013e31821dac86","volume":"21","author":"L Dreer","year":"2012","unstructured":"Dreer L, Girkin C, Mansberger S. Determinants of medication adherence to topical glaucoma therapy. J Glaucoma. 2012;21:234\u201340.","journal-title":"J Glaucoma"},{"key":"482_CR4","first-page":"233","volume":"26","author":"SC Patel","year":"1995","unstructured":"Patel SC, Spaeth GL. Compliance in patients prescribed eye drops for glaucoma. Ophthalmic Surg. 1995;26:233\u20136.","journal-title":"Ophthalmic Surg"},{"key":"482_CR5","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1167\/iovs.07-0290","volume":"48","author":"DS Friedman","year":"2007","unstructured":"Friedman DS, Quigley HA, Gelb L, et al. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Investig Ophthalmol Vis Sci. 2007;48:5052\u20137.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"482_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/jcm5090079","volume":"5","author":"M Feehan","year":"2016","unstructured":"Feehan M, Munger MA, Cooper DK, et al. Adherence to glaucoma medications over 12 months in two US community pharmacy chains. J Clin Med. 2016;5:79.","journal-title":"J Clin Med"},{"key":"482_CR7","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.ophtha.2015.06.039","volume":"122","author":"PA Newman-Casey","year":"2015","unstructured":"Newman-Casey PA, Blachley T, Lee PP, et al. Patterns of glaucoma medication adherence over four years of follow-up. Ophthalmol. 2015;122:2010\u201321.","journal-title":"Ophthalmol"},{"key":"482_CR8","first-page":"189","volume":"1","author":"LR Martin","year":"2005","unstructured":"Martin LR, Williams SL, Haskard KB, Dimatteo MR. The challenge of patient adherence. Ther Clin Risk Manag. 2005;1:189\u201399.","journal-title":"Ther Clin Risk Manag"},{"key":"482_CR9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1080\/09286586.2019.1708121","volume":"27","author":"OJ Killeen","year":"2020","unstructured":"Killeen OJ, Pillai MR, Udayakumar B, et al. Understanding barriers to glaucoma treatment adherence among participants in South India. Ophthal Epidemiol. 2020;27:200\u20138.","journal-title":"Ophthal Epidemiol."},{"key":"482_CR10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2174\/1874944502013010531","volume":"13","author":"S Tshivhase","year":"2020","unstructured":"Tshivhase S, Khoza LB. Challenges contributing to loss to follow-up as experienced by glaucoma patients in the Vhembe District of Limpopo Province, South Africa. Open Public Health J. 2020;13:531\u20137.","journal-title":"Open Public Health J."},{"key":"482_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1177\/1120672120901687","volume":"31","author":"S Guven","year":"2021","unstructured":"Guven S, Koylu MT, Mumcuoglu T. Adherence to glaucoma medication, illness perceptions, and beliefs about glaucoma: attitudinal perspectives among Turkish population. Eur J Ophthalmol. 2021;31:469\u201376.","journal-title":"Eur J Ophthalmol"},{"key":"482_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1590\/S0004-27492010000200003","volume":"73","author":"LR Silva","year":"2010","unstructured":"Silva LR, de Paula JS, Rocha EM, Rodrigues ML. Factors related to glaucoma treatment compliance: patients\u2019 opinions from a University Hospital. Arq Bras Oftalmol. 2010;73:116\u20139.","journal-title":"Arq Bras Oftalmol"},{"key":"482_CR13","doi-asserted-by":"crossref","unstructured":"Abe RY, Wen L de C, Barker GT, Mansberger SL. Psychometric properties of the glaucoma treatment compliance assessment tool (GTCAT) in a Brazilian population. J Glaucoma. 2018;27:257\u201365.","DOI":"10.1097\/IJG.0000000000000876"},{"key":"482_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/IJG.0b013e3182741f1c","volume":"23","author":"G Rees","year":"2014","unstructured":"Rees G, Chong XL, Cheung CY, et al. Beliefs and adherence to glaucoma treatment: a comparison of patients from diverse cultures. J Glaucoma. 2014;23:293\u20138.","journal-title":"J Glaucoma"},{"key":"482_CR15","first-page":"1","volume":"111","author":"SL Mansberger","year":"2013","unstructured":"Mansberger SL, Sheppler CR, McClure TM, et al. Psychometrics of a new questionnaire to assess glaucoma adherence: the Glaucoma Treatment Compliance Assessment Tool (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2013;111:1\u201316.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"482_CR16","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.ajo.2015.03.006","volume":"159","author":"GT Barker","year":"2015","unstructured":"Barker GT, Cook PF, Schmiege SJ, et al. Psychometric properties of the Glaucoma Treatment Compliance Assessment Tool in a multicenter trial. Am J Ophthalmol. 2015;159:1092\u20139.","journal-title":"Am J Ophthalmol"},{"key":"482_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/09286586.2018.1516785","volume":"26","author":"GT Barker","year":"2019","unstructured":"Barker GT, Mansberger SL. Psychometric Properties of the Reduced Version of the Glaucoma Treatment Compliance Assessment Tool (GTCAT). Ophthalm Epidemiol. 2019;26:55\u201362.","journal-title":"Ophthalm Epidemiol"},{"key":"482_CR18","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1097\/IJG.0000000000001616","volume":"29","author":"FG Sanchez","year":"2020","unstructured":"Sanchez FG, Mansberger SL, Newman-Casey PA. Predicting adherence with the glaucoma treatment compliance assessment tool. J Glaucoma. 2020;29:1017\u201324.","journal-title":"J Glaucoma"},{"key":"482_CR19","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.ophtha.2015.03.026","volume":"122","author":"PA Newman-Casey","year":"2015","unstructured":"Newman-Casey PA, Robin AL, Blachley T, et al. Most common barriers to glaucoma medication adherence: a cross-sectional survey. Ophthalmology. 2015;122:1308\u201316.","journal-title":"Ophthalmology"},{"key":"482_CR20","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s13142-015-0315-2","volume":"5","author":"MJ Stirratt","year":"2015","unstructured":"Stirratt MJ, Dunbar-Jacob J, Crane HM, et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015;5:470\u201382.","journal-title":"Transl Behav Med."},{"key":"482_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.ophtha.2021.10.023","volume":"129","author":"YS Shah","year":"2022","unstructured":"Shah YS, Cheng M, Mihailovic A, et al. Patient-reported symptoms demonstrating an association with severity of visual field damage in glaucoma. Ophthalmology. 2022;129:388\u201396.","journal-title":"Ophthalmology"},{"key":"482_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5001\/omj.2011.38","volume":"26","author":"B Jimmy","year":"2011","unstructured":"Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26:155\u20139.","journal-title":"Oman Med J"},{"key":"482_CR23","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1001\/jama.2018.19271","volume":"320","author":"V Kini","year":"2018","unstructured":"Kini V, Ho PM. Interventions to improve medication adherence: a review. JAMA. 2018;320:2461\u201373.","journal-title":"JAMA"},{"key":"482_CR24","doi-asserted-by":"crossref","unstructured":"Cross AJ, Elliott RA, Petrie K, et al. Interventions for improving medication-taking ability and adherence in older adults prescribed multiple medications. Cochrane Database Syst Rev. 2020;5:CD012419.","DOI":"10.1002\/14651858.CD012419.pub2"},{"key":"482_CR25","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1001\/jamaophthalmol.2022.0055","volume":"140","author":"A Delavar","year":"2022","unstructured":"Delavar A, Radha Saseendrakumar B, Weinreb RN, Baxter SL. Racial and ethnic disparities in cost-related barriers to medication adherence among patients with glaucoma enrolled in the National Institutes of Health All of Us Research Program. JAMA Ophthalmol. 2022;140:354\u201361.","journal-title":"JAMA Ophthalmol."},{"key":"482_CR26","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s11606-007-0180-x","volume":"22","author":"BA Briesacher","year":"2007","unstructured":"Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med. 2007;22:864\u201371.","journal-title":"J Gen Intern Med"},{"key":"482_CR27","unstructured":"Guerra G. Popula\u00e7\u00e3o fica sem medicamentos nas farm\u00e1cias de alto custo: o que fazer? Consultor Jur\u00eddico 2022 https:\/\/www.conjur.com.br\/2022-mar-28\/gabriela-guerra-farmacia-alto-custo. Assessed 22 Oct 2022."},{"key":"482_CR28","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.ophtha.2014.11.001","volume":"122","author":"B Sleath","year":"2015","unstructured":"Sleath B, Blalock SJ, Carpenter DM, et al. Ophthalmologist-patient communication, self-efficacy, and glaucoma medication adherence. Ophthalmology. 2015;122:748\u201354.","journal-title":"Ophthalmology"},{"key":"482_CR29","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1365-2710.2001.00363.x","volume":"26","author":"E Vermeire","year":"2001","unstructured":"Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26:331\u201342.","journal-title":"J Clin Pharm Ther"},{"key":"482_CR30","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/S0140-6736(05)66665-2","volume":"365","author":"GS Alexopoulos","year":"2005","unstructured":"Alexopoulos GS. Depression in the elderly. Lancet. 2005;365:1961\u201370.","journal-title":"Lancet"},{"key":"482_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/08820538.2021.1903945","volume":"37","author":"ME Stamatiou","year":"2021","unstructured":"Stamatiou ME, Kazantzis D, Theodossiadis P, Chatziralli I. Depression in glaucoma patients: a review of the literature. Semin Ophthalmol. 2021;37:29\u201335.","journal-title":"Semin Ophthalmol."},{"key":"482_CR32","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s11606-011-1704-y","volume":"26","author":"JL Grenard","year":"2011","unstructured":"Grenard JL, Munjas BA, Adams JL, et al. Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med. 2011;26:1175\u201382.","journal-title":"J Gen Intern Med"}],"container-title":["Pharmaceutical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-023-00482-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40290-023-00482-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-023-00482-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:02:15Z","timestamp":1693180935000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40290-023-00482-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["482"],"URL":"https:\/\/doi.org\/10.1007\/s40290-023-00482-y","relation":{},"ISSN":["1178-2595","1179-1993"],"issn-type":[{"value":"1178-2595","type":"print"},{"value":"1179-1993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]},"assertion":[{"value":"14 May 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data available on request due to privacy\/ethical restrictions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"This study did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Julia C. Andrade, Guilherme S. Motta, and Niro Kasahara declare that they have no conflicts of interest that might be relevant to the contents of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The institutional ethics committee approved the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants signed informed consent to participate in the study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent\u00a0to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors contributed equally to the study conception and design. Julia C. Andrade and Guilherme S. Motta performed data collection and analysis. Niro Kasahara wrote the first draft of the manuscript. All authors read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contribution"}}]}}